X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1665) 1665
Newsletter (595) 595
Publication (122) 122
Newspaper Article (55) 55
Book Review (34) 34
Magazine Article (17) 17
Book Chapter (5) 5
Conference Proceeding (3) 3
Trade Publication Article (3) 3
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
fibric acids (1870) 1870
humans (757) 757
male (557) 557
index medicus (523) 523
animals (503) 503
clofibric acid - analogs & derivatives (397) 397
research (346) 346
gemfibrozil (322) 322
female (321) 321
rats (298) 298
hypolipidemic agents - therapeutic use (269) 269
pharmacology & pharmacy (259) 259
fenofibrate (247) 247
clofibric acid - pharmacology (230) 230
reports (229) 229
middle aged (226) 226
fibric acids - therapeutic use (211) 211
diabetes (192) 192
hypolipidemic agents - pharmacology (182) 182
cholesterol (181) 181
risk factors (179) 179
drugs (177) 177
statins (166) 166
care and treatment (165) 165
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (161) 161
liver - drug effects (161) 161
analysis (157) 157
aged (155) 155
adult (142) 142
mice (139) 139
type 2 diabetes (137) 137
atherosclerosis (136) 136
lipids (130) 130
coronary-heart-disease (127) 127
liver - metabolism (125) 125
triglycerides (125) 125
fenofibrate - therapeutic use (123) 123
low density lipoproteins (121) 121
physiological aspects (121) 121
triglycerides - blood (120) 120
medical research (117) 117
treatment outcome (115) 115
medicine, experimental (112) 112
biochemistry & molecular biology (110) 110
dyslipidemias - drug therapy (108) 108
cardiac & cardiovascular systems (105) 105
cardiovascular diseases (104) 104
fibrates (103) 103
liver (102) 102
toxicology (100) 100
clofibric acid - therapeutic use (97) 97
hypolipidemic agents - adverse effects (97) 97
drug therapy (96) 96
microbodies - drug effects (96) 96
drug therapy, combination (94) 94
pharmaceutical industry (94) 94
hyperlipidemias - drug therapy (93) 93
medicine & public health (92) 92
ciprofibrate (91) 91
fenofibrate - pharmacology (91) 91
cholesterol, hdl - blood (90) 90
cardiovascular diseases - prevention & control (88) 88
endocrinology & metabolism (85) 85
prevention (81) 81
metabolism (80) 80
coronary heart disease (79) 79
medicine, general & internal (79) 79
rats, inbred f344 (79) 79
time factors (79) 79
cells, cultured (78) 78
hypolipidemic agents - administration & dosage (78) 78
cardiovascular agents (77) 77
dyslipidemia (77) 77
fatty acids (77) 77
health aspects (76) 76
liver - enzymology (76) 76
peripheral vascular disease (75) 75
clofibrate (73) 73
enzymes (73) 73
pharmacology/toxicology (72) 72
cardiology (70) 70
hypercholesterolemia (70) 70
rats, sprague-dawley (70) 70
lipids - blood (69) 69
ppar-alpha (69) 69
risk (69) 69
cardiovascular (68) 68
cardiovascular disease (68) 68
dose-response relationship, drug (68) 68
hyperlipidemia (68) 68
bezafibrate (66) 66
cholesterol, ldl - blood (66) 66
type-2 diabetes-mellitus (66) 66
inflammation (64) 64
cardiovascular-disease (63) 63
universities and colleges (63) 63
metabolic syndrome (62) 62
clofibrate - analogs & derivatives (60) 60
diabetes therapy (60) 60
niacin - therapeutic use (60) 60
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2244) 2244
French (26) 26
German (17) 17
Spanish (10) 10
Japanese (8) 8
Russian (7) 7
Hungarian (6) 6
Portuguese (6) 6
Chinese (3) 3
Czech (3) 3
Korean (3) 3
Polish (2) 2
Danish (1) 1
Italian (1) 1
Romanian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biochemistry, ISSN 0006-2960, 12/2013, Volume 52, Issue 51, pp. 9347 - 9357
Although the human liver fatty acid binding protein (L-FABP) T94A variant arises from the most commonly occurring single-nucleotide polymorphism in the entire... 
BACKBONE DYNAMICS | L-FABP | PPAR-ALPHA | LIGAND-BINDING | RAT | PROLIFERATOR-ACTIVATED RECEPTORS | BIOCHEMISTRY & MOLECULAR BIOLOGY | LOW-DENSITY-LIPOPROTEIN | GENETIC-VARIANTS | PEROXISOME PROLIFERATORS | PHYTANIC ACID | Hypolipidemic Agents - metabolism | Humans | Phytanic Acid - pharmacology | Fatty Acid-Binding Proteins - metabolism | Fenofibrate - pharmacology | Fatty Acid Transport Proteins - metabolism | Fatty Acid Transport Proteins - agonists | Protein Stability | Binding Sites | Recombinant Proteins - metabolism | Protein Structure, Secondary | Fatty Acid-Binding Proteins - agonists | Fenofibrate - metabolism | Liver - metabolism | Cells, Cultured | Fenofibrate - analogs & derivatives | Rats | Recombinant Proteins - chemistry | PPAR alpha - genetics | Hot Temperature | Hypolipidemic Agents - pharmacology | Phytanic Acid - metabolism | Fatty Acid-Binding Proteins - genetics | Gene Expression Regulation - drug effects | Animals | Fibric Acids - metabolism | Fatty Acid-Binding Proteins - chemistry | Ligands | PPAR alpha - agonists | Liver - cytology | Mice | Polymorphism, Single Nucleotide | PPAR alpha - metabolism | Fatty Acid Transport Proteins - genetics | Fibric Acids - pharmacology | Amino Acid Substitution | Proteolipids | Lipoproteins | Physiological aspects | Chemical properties | Research | Blood lipoproteins | Fibric acids | liver | fibrate | human
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/1997, Volume 94, Issue 9, pp. 4318 - 4323
Journal Article
European Heart Journal, ISSN 0195-668X, 1/2010, Volume 31, Issue 2, pp. 149 - 164
Journal Article
Chemico-Biological Interactions, ISSN 0009-2797, 2006, Volume 160, Issue 3, pp. 241 - 251
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/1997, Volume 94, Issue 9, pp. 4312 - 4317
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2018, Volume 378, Issue 23, pp. 2171 - 2181
Journal Article
Journal Article
Toxicology and Applied Pharmacology, ISSN 0041-008X, 2011, Volume 251, Issue 3, pp. 201 - 208
Gemfibrozil (GEM) is a fibrate drug consistently found in effluents from sewage treatment plants. This study characterizes the pharmacological effects of GEM... 
Fish | Lipid metabolism | PPAR | Triacylglycerol | Aquatic toxicology | Fatty acid | PEROXISOME-PROLIFERATOR | FATTY-ACID-COMPOSITION | PROLIFERATOR-ACTIVATED RECEPTORS | ONCORHYNCHUS-MYKISS | CARASSIUS-AURATUS | TREATMENT PLANTS | LONG-DISTANCE MIGRATION | DENSITY-LIPOPROTEIN | PHARMACOLOGY & PHARMACY | SALMON SALMO-SALAR | TOXICOLOGY | CORONARY-HEART-DISEASE | Sewage - chemistry | Fatty Acids, Omega-3 - metabolism | Liver - metabolism | Lipoprotein Lipase - drug effects | PPAR alpha - genetics | Oncorhynchus mykiss | PPAR-beta - genetics | Gemfibrozil - toxicity | Gene Expression Regulation - drug effects | Animals | Water Pollutants, Chemical - toxicity | Liver - drug effects | Hypolipidemic Agents - toxicity | Lipoproteins - metabolism | Female | Lipoproteins - drug effects | Fatty Acids - metabolism | Lipoprotein Lipase - metabolism | PPAR gamma - genetics | Unsaturated fatty acids | Animal behavior | Trout | Low density lipoproteins | Fishes | Gemfibrozil | Physiological aspects | Lipids | Lipoprotein lipase | Gene expression | Omega-3 fatty acids | Fibric acids | Index Medicus | AQUATIC ORGANISMS | HYDROLASES | WASTE PROCESSING | CHOLESTEROL | STEROIDS | DMSO | ECOLOGICAL CONCENTRATION | ENVIRONMENT | PROCESSING | CARBOXYLESTERASES | 60 APPLIED LIFE SCIENCES | DENSITY | SULFOXIDES | HYDROXY COMPOUNDS | METABOLISM | ENZYMES | DRUGS | GENES | ESTERS | ORGANIC SULFUR COMPOUNDS | PHYSICAL PROPERTIES | FISHES | VERTEBRATES | LIPIDS | ANIMALS | MEMBRANE PROTEINS | LIPASES | MANAGEMENT | LIQUID WASTES | ORGANIC COMPOUNDS | STEROLS | ORGANIC ACIDS | PHOSPHOLIPIDS | WASTES | ESTERASES | WASTE MANAGEMENT | TROUT | ORGANIC PHOSPHORUS COMPOUNDS | CARBOXYLIC ACIDS | RECEPTORS | PROTEINS | LIPOPROTEINS
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 10/2015, Volume 32, Issue 10, pp. 3432 - 3446
Journal Article